Morton Goldberg, Director at EYEGATE PHARMACEUTICALS INC (EYEG), sold 8,919 shares at $3.00 ($27K) on 2017-03-06, disclosed to the SEC on 2017-03-06.
Open-market sale of $27k EYEG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EYEG | SELL | 2016-06-15 | $47K | — | Filing → |
| EYEG | SELL | 2016-06-07 | $72K | — | Filing → |